Overexpression of the Mitochondrial Folate and Glycine–Serine Pathway: A New Determinant of Methotrexate Selectivity in Tumors (Q42722444)
scientific article published on November 7, 2012
Language:
(P31) (Q13442814)
(P304) 478-482
(P407) (Q1860)
(P433) 2
(P478) 73
(P577) Wednesday, November 7, 2012
(P921) (Q61643320)
(Q127060)
(Q422232)
(P953) https://cancerres.aacrjournals.org/content/canres/73/2/478.full.pdf
https://europepmc.org/articles/PMC4083755
https://europepmc.org/articles/PMC4083755?pdf=render
https://doi.org/10.1158/0008-5472.can-12-3709
https://aacrjournals.org/cancerres/article-pdf/73/2/478/2693474/478.pdf
(P1433) (Q326097)
(P1476) "Overexpression of the mitochondrial folate and glycine-serine pathway: a new determinant of methotrexate selectivity in tumors" (language: en)
"Overexpression of the Mitochondrial Folate and Glycine–Serine Pathway: A New Determinant of Methotrexate Selectivity in Tumors" (language: en)
(P2093) Alexei Vazquez
Philip M. Tedeschi
Joseph R. Bertino
(P2860) (Q42404762)
(Q36215852)
(Q36477750)
(Q29547695)
(Q39416388)
(Q34071505)
(Q39751877)
(Q37087191)
(Q28506233)
(Q29615393)
(Q28472573)
(Q34632326)
(Q24337187)
(Q24792966)
(Q28565518)
(Q34552178)
(Q51940347)
(Q40046962)
other details
description scientific article published on November 7, 2012

External Links